Soussi T - Search Results

1

Pediatric Cancer Variant Pathogenicity Information Exchange (PeCanPIE): a cloud-based platform for curating and classifying germline variants.

Edmonson MN, Patel AN, Hedges DJ, Wang Z, Rampersaud E, Kesserwan CA, Zhou X, Liu Y, Newman S, Rusch MC, McLeod CL, Wilkinson MR, Rice SV, Soussi T, Taylor JP, Benatar M, Becksfort JB, Nichols KE, Robison LL, Downing JR, Zhang J. Edmonson MN, et al. Among authors: soussi t. Genome Res. 2019 Sep;29(9):1555-1565. doi: 10.1101/gr.250357.119. Epub 2019 Aug 22. Genome Res. 2019. PMID: 31439692 Free PMC article.

2

Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice.

Leroy B, Ballinger ML, Baran-Marszak F, Bond GL, Braithwaite A, Concin N, Donehower LA, El-Deiry WS, Fenaux P, Gaidano G, Langerød A, Hellstrom-Lindberg E, Iggo R, Lehmann-Che J, Mai PL, Malkin D, Moll UM, Myers JN, Nichols KE, Pospisilova S, Ashton-Prolla P, Rossi D, Savage SA, Strong LC, Tonin PN, Zeillinger R, Zenz T, Fraumeni JF Jr, Taschner PE, Hainaut P, Soussi T. Leroy B, et al. Among authors: soussi t. Cancer Res. 2017 Mar 15;77(6):1250-1260. doi: 10.1158/0008-5472.CAN-16-2179. Cancer Res. 2017. PMID: 28254861 Free PMC article. Review.

3

Seshat: A Web service for accurate annotation, validation, and analysis of TP53 variants generated by conventional and next-generation sequencing.

Tikkanen T, Leroy B, Fournier JL, Risques RA, Malcikova J, Soussi T. Tikkanen T, et al. Among authors: soussi t. Hum Mutat. 2018 Jul;39(7):925-933. doi: 10.1002/humu.23543. Epub 2018 May 17. Hum Mutat. 2018. PMID: 29696732 Free article.

4

High prevalence of cancer-associated TP53 variants in the gnomAD database: A word of caution concerning the use of variant filtering.

Soussi T, Leroy B, Devir M, Rosenberg S. Soussi T, et al. Hum Mutat. 2019 May;40(5):516-524. doi: 10.1002/humu.23717. Epub 2019 Mar 28. Hum Mutat. 2019. PMID: 30720243 Free article.

5

Benign SNPs in the Coding Region of TP53: Finding the Needles in a Haystack of Pathogenic Variants.

Soussi T. Soussi T. Cancer Res. 2022 Oct 4;82(19):3420-3431. doi: 10.1158/0008-5472.CAN-22-0172. Cancer Res. 2022. PMID: 35802772 Review.

6

Cancer associated variant enrichment CAVE, a gene agnostic approach to identify low burden variants in chronic lymphocytic leukemia.

Yaacov A, Lazarian G, Pandzic T, Weström S, Baliakas P, Imache S, Lefebvre V, Cymbalista F, Baran-Marszak F, Rosenberg S, Soussi T. Yaacov A, et al. Among authors: soussi t. Sci Rep. 2024 Sep 20;14(1):21962. doi: 10.1038/s41598-024-73027-1. Sci Rep. 2024. PMID: 39304718 Free PMC article.

7

MUT-TP53 2.0: a novel versatile matrix for statistical analysis of TP53 mutations in human cancer.

Soussi T, Hamroun D, Hjortsberg L, Rubio-Nevado JM, Fournier JL, Béroud C. Soussi T, et al. Hum Mutat. 2010 Sep;31(9):1020-5. doi: 10.1002/humu.21313. Hum Mutat. 2010. PMID: 20572016

8

TP53 mutations in human cancer: database reassessment and prospects for the next decade.

Soussi T. Soussi T. Adv Cancer Res. 2011;110:107-39. doi: 10.1016/B978-0-12-386469-7.00005-0. Adv Cancer Res. 2011. PMID: 21704230 Review.

9

Locus-specific databases in cancer: what future in a post-genomic era? The TP53 LSDB paradigm.

Soussi T. Soussi T. Hum Mutat. 2014 Jun;35(6):643-53. doi: 10.1002/humu.22518. Epub 2014 Mar 5. Hum Mutat. 2014. PMID: 24478183 Review.

10

Recommendations for analyzing and reporting TP53 gene variants in the high-throughput sequencing era.

Soussi T, Leroy B, Taschner PE. Soussi T, et al. Hum Mutat. 2014 Jun;35(6):766-78. doi: 10.1002/humu.22561. Epub 2014 May 6. Hum Mutat. 2014. PMID: 24729566 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters